BioXcel Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 1.84 M | $2.94 M | 78.51% | 12.93% |
| VANGUARD GROUP INC | 01/29/2026 | 292.75 K | $468.41 K | 52.38% | 2.06% |
| OAKTREE CAPITAL MANAGEMENT LP | 02/17/2026 | 241.19 K | $385.90 K | 0.00% | 1.70% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 206.17 K | $329.87 K | 64.62% | 1.45% |
| JONES FINANCIAL COMPANIES LLLP | 02/17/2026 | 137.69 K | $220.30 K | 282.47% | 0.97% |
| JANE STREET GROUP, LLC | 02/12/2026 | 127.50 K | $204.00 K | 100.00% | 0.90% |
| GSA CAPITAL PARTNERS LLP | 02/06/2026 | 120.10 K | $192.00 K | 100.00% | 0.85% |
| FMR LLC | 02/17/2026 | 90.30 K | $144.48 K | -54.53% | 0.64% |
| BLACKROCK, INC. | 02/12/2026 | 84.40 K | $135.03 K | 0.14% | 0.59% |
| STATE STREET CORP | 02/13/2026 | 63.22 K | $101.15 K | 19.92% | 0.45% |
| MAN GROUP PLC | 02/17/2026 | 56.83 K | $90.92 K | 100.00% | 0.40% |
| OAKTREE FUND ADVISORS, LLC | 02/17/2026 | 42.91 K | $68.66 K | 0.00% | 0.30% |
| HIGHTOWER ADVISORS, LLC | 02/06/2026 | 41.00 K | $65.60 K | 17.14% | 0.29% |
| NORTHERN TRUST CORP | 02/17/2026 | 38.37 K | $61.39 K | 1.69% | 0.27% |
| UBS GROUP AG | 01/29/2026 | 38.34 K | $61.34 K | -11.95% | 0.27% |
| HRT FINANCIAL LP | 02/12/2026 | 18.06 K | $28.00 K | 100.00% | 0.13% |
| TWO SIGMA SECURITIES, LLC | 02/17/2026 | 17.07 K | $27.31 K | 100.00% | 0.12% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 15.75 K | $25.20 K | 4.42% | 0.11% |
| DIVERSIFY WEALTH MANAGEMENT, LLC | 02/03/2026 | 15.00 K | $30.75 K | 0.00% | 0.11% |
| ENGINEERS GATE MANAGER LP | 02/17/2026 | 12.30 K | $19.69 K | 100.00% | 0.09% |
| PORTFOLIO STRATEGIES, INC. | 01/27/2026 | 12.18 K | $19.49 K | 100.00% | 0.09% |
| CITIGROUP INC | 02/13/2026 | 12.08 K | $19.33 K | 3,302.54% | 0.09% |
| IFP ADVISORS, INC | 02/06/2026 | 4.37 K | $6.99 K | 0.00% | 0.03% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 4.33 K | $6.92 K | -73.49% | 0.03% |
| GROUP ONE TRADING, L.P. | 02/12/2026 | 3.19 K | $5.10 K | 41.62% | 0.02% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 03/04/2026 | 1.64 K | $2.63 K | 100.00% | 0.01% |
| MORGAN STANLEY | 02/13/2026 | 1.46 K | $2.34 K | -10.79% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.45 K | $2.31 K | -78.99% | 0.01% |
| NEWEDGE ADVISORS, LLC | 02/18/2026 | 1.33 K | $2.13 K | 0.00% | 0.01% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 169 | $270 | 0.00% | 0.00% |
| WASHINGTON TRUST ADVISORS, INC. | 02/03/2026 | 160 | $256 | 0.00% | 0.00% |
| PARKSIDE FINANCIAL BANK & TRUST | 02/13/2026 | 112 | $180 | 0.00% | 0.00% |
| ANNIS GARDNER WHITING CAPITAL ADVISORS, LLC | 02/09/2026 | 112 | $180 | 100.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 02/06/2026 | 60 | $96 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 02/11/2026 | 45 | $72 | 0.00% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 01/23/2026 | 25 | $40 | 100.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 02/10/2026 | 21 | $34 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 12 | $19 | -69.23% | 0.00% |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 01/27/2026 | 2 | $3 | -98.06% | 0.00% |
| US BANCORP \DE\ | 01/30/2026 | 1 | $2 | 0.00% | 0.00% |
| TRIUMPH CAPITAL MANAGEMENT | 02/12/2026 | 1 | $2 | 0.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| FOUNDATIONS INVESTMENT ADVISORS, LLC | 02/10/2026 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| SLT HOLDINGS LLC | 02/09/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
BioXcel Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 57 institutional investors and hedge funds held shares of BioXcel Therapeutics Inc. The most heavily invested institutionals were:
VANGUARD FIDUCIARY TRUST CO: 84,921
UBS Group AG: 52,788
HighTower Advisors, LLC: 41,000
DIVERSIFY WEALTH MANAGEMENT, LLC: 15,000
Portfolio Strategies, Inc.: 12,178
WELLS FARGO & COMPANY/MN: 4,319
24.91% of BioXcel Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 3.82 M shares in the last 24 months. This purchase volume represents approximately $6.62 M in transactions.